Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

The past four trading days have held roughly the same price areas within the major indices. Specifically, the S&P 500 (SPY) and the Nasdaq 100 (QQQ) have similar tight price action.

Is Biotech Sector (IBB) Looking for Major Price Move?

VanEck Vectors Biotech ETF

Invesco Nasdaq Biotechnology ETF

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share buybacks. On Tuesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) was down 0.1%, the iShares Biotechnology ETF (IBB) fell 0.1%, and the VanEck Vectors Biotech ETF (BBH) was unchanged.

Biotech ETFs Muddled Despite Amgen Strength

AdvisorShares Pure US Cannabis ETF

SPDR S&P Biotech ETF

They've taken a beating, but the industries they track are still growing.

3 Growth ETFs to Consider Buying During This Correction

2021 has been a real tough year for biotech investors, and the start of 2022 doesn't bring a sign of relief yet. Nonetheless, if history is of any guide, large trading volumes over the past month are an indication that better days might be waiting ahead.

Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead

For roughly three months the biotechnology ETF (IBB) has been trending lower.  Though it's made multiple attempts to clear the 50-Day moving average (DMA), it has failed.

How Biotech ETF (IBB) Confirmed Reversal Pattern in Price and Momentum

Roundhill Sports Betting & iGaming ETF

Amplify Cybersecurity ETF

Amplify Mobile Payments ETF

Proshares Online Retail ETF

J.P. Moggan strategists believe that these high-beta ETF areas could winning picks for January 2022.

Play 5 High-Beta ETF Areas for January & Be a Bottom Fisher

Virtus LifeSci Biotech Clinical Trials ETF

ALPS Medical Breakthroughs ETF

Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren't enough aimed at smaller biotechnology companies. As is often the case, market observers are forecasting an uptick in biotechnology consolidation activity next year.

Biotech M&A Could Finally Perk Up in 2022

ETF Battles: IBB Vs XBI

Gracell Biotechnologies

SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Dec. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq: NBI).

Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index

Curis

LEXINGTON, Mass., Dec. 15, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI) and the iShares Biotechnology ETF (NYSE: IBB).

Curis to be Added to the Nasdaq Biotechnology Index and the iShares Biotechnology ETF

If there's an asset class that's looking forward to 2022, it's small- and mid-cap (SMID) biotechnology stocks because that group dealt with a variety of headwinds this year. However, there are more reasons for investors to monitor exchange traded funds, such as the ALPS Medical Breakthroughs ETF (SBIO), beyond “things can't get much worse” sentiment.

Smaller Biotech Stocks Ready to Perk Up

Invesco NASDAQ Internet ETF

Invesco S&P 500 Equal Weight Technology ETF

Vanguard Mid-Cap Value ETF

Financial Select Sector SPDR Fund

Take a look at some top-ranked ETFs that might help strengthen your portfolio and rake in some good returns.

5 Top-Ranked ETFs to Invest in December

Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms.

IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022

Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechnology sector-related exchange traded funds. On Monday, the Invesco Nasdaq Biotechnology ETF (IBBQ) rose 1.4% and iShares Biotechnology ETF (IBB) gained 1.7%.

Moderna's Omicron Booster Strategy Lifts Biotechnology ETFs

Global X Cloud Computing ETF

Amplify Video Game Tech ETF

Amplify Online Retail ETF

VanEck Vectors Semiconductor ETF

Direxion Work From Home ETF

COVID-19 lockdowns in Europe once again stirred fears of further spread of infections. This raises the chances of another wave of COVID-19 in other parts of the world, which could boost the demand for stay-at-home stocks and ETFs.

6 Stay-at-Home ETFs Likely to Gain on Renewed Lockdown Fears

iShares Russell 2000 ETF

iShares Transportation Average ETF

SPDR S&P Regional Banking ETF

SPDR S&P Retail ETF

Mish's Economic Modern Family consists of 5 key sector ETFs, one major index ETF, and Bitcoin.  Bring them all together and you have an easy and quick way to look at the market, grasp overall trends, and see where potential pressure is leaning.

7 ETFs That Offer Complete Picture Of Stock Market

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

Can Biotech ETFs Gain From Positive Booster Update?

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month.

IBB: Healthcare Dashboard For October

Despite suffering significant losses recently, biotechnology stocks and ETFs have seen some impressive gains over the last year or so, as coronavirus vaccines have propelled companies like Pfizer and Moderna to new heights. However, some analysts believe that the sector could have even more upside in store.

Could Biotech ETFs Be Due For More Upside?

ProShares Ultra Nasdaq Biotechnology

iShares Genomics Immunology and Healthcare ETF

iShares Evolved U.S. Innovative Healthcare ETF

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

Take a Look at the Top-Performing Biotech ETFs YTD

It could perhaps deliver a much bigger gain than 100%.

Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years

This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to pursue lower drug prices.

Biotech Stocks Have Colds, but They Can Heal

Global X Telemedicine & Digital Health ETF

Global X Education ETF

iShares S&P 500 Value ETF

iShares U.S. Technology ETF

Vanguard Mega Cap Value ETF

Vanguard Information Technology ETF

Technology Select Sector SPDR Fund

Let's take a look at some ETF areas that can be good investment options for September.

Best ETF Areas for Placing Your Bets in September

Invesco QQQ

SPDR S&P 500 ETF Trust

Monday, both the S&P 500 (SPY) and the Nasdaq 100 (QQQ) again climbed to new highs. While the large-cap indices continue to lead the market, the Economic Modern Family made little progress.

News for iShares Nasdaq Biotechnology ETF ETF (IBB)